OCON's technology has a higher safety profile than
traditional IUDs as its built-in safety mechanism allows the device
to deploy and position itself away from the uterine walls
LONDON, April 23, 2021 /PRNewswire/ -- Based on its
recent analysis of the global intrauterine device (IUD) market,
Frost & Sullivan recognizes OCON Healthcare (OCON) with the
2021 Global Enabling Technology Leadership Award for creating the
world's first and only 3D spherical copper IUD, the Intra Uterine
Ball (IUB)™ Ballerine®. The IUD is made from nitinol, a
super-elastic alloy that can retain shape and is an ideal
transporter of drugs to the uterus to treat various health
conditions. The company develops, manufactures, and globally
commercializes its technologically superior IUDs based on its
proprietary IUB™ platform.
"OCON's flagship product, IUB™ Ballerine®, is a hormone-free and
flexible birth control device that remains effective for up to five
years and has an efficiency rate of more than 99% in preventing
pregnancy. Its safety, quality, and comfort advantages have already
earned it a global customer base," said Suchismita Das, Industry Analyst. "IUB™
Ballerine®'s small form factor and 'smartness' help it easily adapt
to the contractions and movements of the uterus, minimizing the
risks of damage and irritation associated with conventional
T-shaped devices."
Understanding the myriad of issues women face with rigid
T-shaped IUDs, OCON created the IUB™ Ballerine® to be uniquely
spherical and small (15 mm in diameter). It also demonstrates an
improved safety profile, leading to fewer perforations,
malposition, and ectopic pregnancies. The device has already
received four global regulatory approvals, including Conformité
Européenne's (CE) approval. It is suitable for young women from 15
years of age who wish to delay pregnancy as their fertility is not
affected upon removing the device.
Beyond IUB™ Ballerine®, OCON's pipeline includes the IUB™
spherical endometrial ablation device (SEAD™), a non-hormonal
treatment for women suffering from heavy menstrual bleeding and/or
abnormal uterine bleeding. The ablation device is safer than the
current standard of care for global endometrial ablation, which is
invasive, expensive, and can cause uterine wall adhesions and/or
hysterectomies. SEAD™ is expected to be an effective and nearly
pain-free solution that improves the quality of life for women.
"OCON's IUB™ Ballerine® and promising SEAD™ offerings as well as
its forward looking pipeline of solutions in development for
fibroids, endometriosis, cancers and other hormonal therapies, have
positioned it as a pioneer in the conceptualization, development,
manufacture, and commercialization of 'smart' 3D IUDs," noted Das.
"Its technology is available in 30 countries, including
Israel, South Africa, and member countries of the
European Union. Its exceptional properties have increased its
acceptance rates among women of different age groups and position
the company for continued domination of the femtech space."
Each year, Frost & Sullivan presents this award to a company
that has developed a pioneering technology that not only enhances
current products, but also enables the development of new products
and applications. The award recognizes the high market acceptance
potential of the recipient's technology.
Frost & Sullivan Best Practices awards recognize companies
in a variety of regional and global markets for demonstrating
outstanding achievement and superior performance in areas such as
leadership, technological innovation, customer service, and
strategic product development. Industry analysts compare market
participants and measure performance through in-depth interviews,
analysis, and extensive secondary research to identify best
practices in the industry.
About Frost & Sullivan
For six decades, Frost & Sullivan has been world-renowned
for its role in helping investors, corporate leaders, and
governments navigate economic changes and identify disruptive
technologies, Mega Trends, new business models, and companies to
action, resulting in a continuous flow of growth opportunities to
drive future success. Contact us: Start the discussion.
Contact:
Lindsey Whitaker
P: +1 (210) 477-8457
E: lindsey.whitaker@frost.com
About OCON Healthcare
OCON Healthcare – a fem-health revolution led by women for women
- innovates, develops, manufactures, and commercializes
cutting-edge women's health products based on its patented IUB™
(Intra Uterine Ball) proprietary
platform with the mission to improve and impact women's health
and quality of life.
www.oconmed.com
info@oconmed.com